Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: A simulation for the EU G5 countries

Ivo Abraham, Lucy Han, Diana Sun, Karen Macdonald, Matti Aapro

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: A simulation for the EU G5 countries'. Together they form a unique fingerprint.

Medicine & Life Sciences